AMY ENGELMANN: Open Payments
NPI 1902459761 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 23 payments from 11 companies in 2025. Trend: 2023 $807 · 2024 $1,096 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 5 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| GENZYME CORPORATION | 2 | $51 |
| JAZZ PHARMACEUTICALS INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Optinose US, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: DUPIXENT, NUCALA, Hizentra, XYWAV, Andembry, XHANCE, TAKHZYRO, WAKIX.
Industry payments across NY — which companies pay providers there.
